AASPA Newsline
May. 26, 2015

2015 AASPA CME Meeting & Surgical Update

We hope you will join us Oct. 1 – 4, 2015 at the Hilton Suites Chicago/Magnificent Mile, Chicago, Illinois, for our 15th Annual AASPA CME Meeting.

Join fellow surgical PAs, PA educators, PA students, pre-PA students and surgical industry leaders at the 15th Annual Surgical CME, preceding the Annual Clinical Congress of the American College of Surgeons!

This exciting, hands-on surgical meeting will be held at the fabulous Hilton Suites Chicago in the heart of incredible Chicago.

If you are looking for a qualified surgical PA, this is the ideal venue to fill that position. For industry exhibitors looking for "high touch face time" with surgical PAs, this is the ideal meeting for you!More

Register now for the 2015 FCCS — Fundamental Critical Care Support

Management principles for the first 24 hours of critical care. Two-day course — 16 hours of CME and Certificate of Completion and card.

Course will be held before the 15th Annual AASPA CME Meeting at the Hilton Suites Chicago/Magnificent Mile.

Register today!More

Study: Generic as good as name brand for post-transplant drugs
By Lynn Hetzler
Generic formulations of tacrolimus are as effective as the name-brand version, according to a recent study. Researchers enrolled 70 kidney and liver transplant patients into a prospective, blinded, six-way crossover study. The scientists used two different types of generic versions of tacrolimus, which is used postoperatively to lower the risk for organ rejection. The focus of the study, funded by the U.S. Food and Drug Administration, was to investigate whether these two disparate tacrolimus generic versions are bioequivalent to the brand name tacrolimus product, Prograf, in stable patients.More

Does biology or therapy define oncology outcomes?
OncLive
The debate over the relative impact on survival outcomes of therapy versus the inherent biology of an individual patient’s cancer remains one of the most controversial areas in all of cancer medicine. Even the results of well-designed and conducted phase III clinical trials cannot alter the opinion of many that observed equivalent survival outcomes between different therapeutic strategies are clinically irrelevant since “treatment in the study was not optimally applied.”More

Cilostazol may be safe bridging strategy to stop DAPT during surgery
Healio
Patients with a high-risk paclitaxel-eluting stent who were given cilostazol before undergoing a surgical procedure safely transitioned off dual antiplatelet therapy and had low rates of bleeding and major adverse cardiac events during surgery, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions. Charles L. Laham, M.D., FSCAI, and colleagues reported 8-year experience with outpatient cilostazol bridging in patients with paclitaxel-eluting stents who underwent surgery during the at-risk period.More

Work-life balance in healthcare: Realign your priorities
By Catherine Iste
As a healthcare professional, your work requires you to be there for others, but how can you do that effectively if you haven't taken care of yourself? Now that you are acutely aware of where your hours go, it's time to look at what you can do realign your time with your priorities. Lisa Cole, MS, RN, FNP, has spent more than 35 years in the healthcare industry. Her current business, Re-Source, focuses on helping people live and die well via lifestyle change, patient advocacy and care coordination. Through her work, Cole has learned three areas that can help reduce stress now and help you be more present as a caregiver. More

Can the robot be cost-effective for general surgery?
General Surgery News
Debate over the value of robotic surgery is far from resolved. General surgeons tend to agree that the current robotic platform delivers what it promises — enhanced visualization, dexterity and control on the part of surgeon — but that these perks come at a high financial investment. Given the costs, it is unclear whether robotic surgery can become cost-efficient and thus whether the surgical community can justify its use.More

Limits urged on surgeries by low-volume providers
Health Leaders Media
An initiative by three major U.S. health systems aims to "minimize the number of patients who wind up getting their care by so-called 'hobbyists,' surgeons and hospitals that seldom do these procedures," says one of its chief proponents. Leaders at Dartmouth-Hitchcock Medical Center, The Johns Hopkins Hospital and Health System, and the University of Michigan Health System are urging other systems to join their combined 20 hospitals in the "Take the Volume Pledge" campaign to place limits on surgical procedures.More

Wireless retinal implant could restore functional sight
The Jerusalem Post
An innovative retinal implant that could restore vision in a resolution five times better than existing devices has been produced by an international team that included researchers from Bar-Ilan University in Ramat Gan. The development was described in a recent issue of Nature Medicine. The retinal implant — a 30-micrometer-thin, photovoltaic pixel array implanted beneath the retina — converts incoming infrared light into electric current — which stimulates the retinal neurons that remain functional, allowing them to send messages to the visual center of the brainMore

Chiefs, with tougher cases, see more complications than interns
General Surgery News
Chief residents have a higher rate of surgical complications, longer operative times and longer hospital lengths of stay than new residents, according to the results of a study presented at the 2015 Southeastern Surgical Congress. This can be explained by patient acuity and autonomy differences because interns are more likely observing cases and chief residents are given more autonomy in the operating room, said lead investigator Vedra Augenstein, M.D., a general surgeon at Carolinas Medical Center, in Charlotte, North Carolina.More